5fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma

Author：                    

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.6, 2012-01, pp. : 1195-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma

By                

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 712-720

Spandidos Publications

Access to resources Recommend Favorite

Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model

By                    

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 667-672

Spandidos Publications

Access to resources Recommend Favorite

Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma

By Tai Cheng-Jeng  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 931-932

Informa Healthcare

Access to resources Recommend Favorite

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma

By            

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2562-2568

Spandidos Publications

Access to resources Recommend Favorite

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah   Larkin James   Pickering Lisa  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite